EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 22-Jun-2026 10:16 ET (22-Jun-2026 14:16 GMT/UTC)

7-Apr-2026

American Cancer Society grant to fund research on urinary tract cancer therapies

Weill Cornell Medicine
Grant and Award Announcement

A $1 million Research Scholar Grant from the American Cancer Society will help a multi-institution team led by Dr. Bishoy Faltas, associate professor of medicine at Weill Cornell Medicine, to develop new therapy combinations for hard-to-treat urinary tract cancers.

7-Apr-2026

Ulrich Steidl, MD, Ph.D., named director of Montefiore Einstein Comprehensive Cancer Center

Albert Einstein College of Medicine
Business Announcement

International leader in blood cancer and stem cell research, Ulrich Steidl, M.D., Ph.D., has been named director of the Montefiore Einstein Comprehensive Cancer Center (MECCC) and vice president of cancer medicine at Montefiore Einstein. He has acted as interim director of MECCC, which is a National Cancer Institute (NCI)-designated comprehensive cancer center, since late 2025.

7-Apr-2026

NYU Abu Dhabi researchers develop smart MRI molecules to detect and treat cancer

New York University
Peer-Reviewed Publication

Researchers at NYU Abu Dhabi have developed smart molecules that can both detect and treat cancer, offering a safer and more precise approach to care.

Journal: Journal of the American Chemical Society

7-Apr-2026

Scripps Research scientists uncover new mechanism cancer cells use to survive DNA damage

Scripps Research Institute
Peer-Reviewed Publication

Discovery reshapes understanding of how tumor cells repair broken DNA, pointing toward more precise cancer therapies.

Journal: Molecular Cell

7-Apr-2026

Researchers study shifts in cancer mortality

Mississippi State University
Peer-Reviewed Publication

Researchers at Mississippi State's Social Science Research Center, in partnership with scientists at Oak Ridge National Laboratory, analyzed cancer deaths in almost 3,000 U.S. counties from 1981-2019, finding urban and affluent counties were more likely to experience a significant decline in cancer mortality.

Journal: British Journal of Cancer

7-Apr-2026

Four Keck School of Medicine of USC researchers elected as senior members of the National Academy of Inventors

Keck School of Medicine of USC
Grant and Award Announcement

The National Academy of Inventors (NAI), a nonprofit member organization that promotes academic technology and innovation, has named four Keck School of Medicine of USC faculty as new senior members: Paula Cannon, PhD; Alan Epstein, MD, PhD; Heinz-Josef Lenz, MD; and Bodour Salhia, PhD.

The new senior members will be welcomed at the 2026 NAI conference, hosted by USC at Loews Hollywood Hotel from June 1 to 4.

NAI senior members are recognized for their work producing innovative technologies that have the potential for real impact on the welfare of society, as well as success in patents, licensing and commercialization. This year’s members from the Keck School of Medicine are being recognized for their innovations in cancer and HIV.

Meeting: 2026 National Academy of Inventors conference

7-Apr-2026

Trends and disparities in the use of next-generation sequencing in patients with cancer in the US

JAMA Network
Peer-Reviewed Publication

About The Study: In this cohort study, most patients with advanced or metastatic cancers did not undergo tumor genomic testing. Low socioeconomic status, Black race or Hispanic ethnicity, and Medicaid or Medicare coverage were associated with significantly longer time to next-generation sequencing, highlighting the need for awareness and health care policies aimed at bridging these gaps.

Journal: JAMA Network Open

7-Apr-2026

Researchers develop AI tool to predict Barrett’s esophagus recurrence after therapy

University of Colorado Anschutz
Peer-Reviewed Publication

A new artificial intelligence (AI)–based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett’s esophagus (BE) related dysplasia and early esophageal adenocarcinoma. BE, is the only known condition that precedes esophageal adenocarcinoma - an aggressive cancer with high mortality rates.

Developed and validated by U.S. researchers, the AI model was over 90% accurate at predicting which patients would experience a recurrence of BE after endoscopic eradication therapy (EET) and detecting when it’s likely to occur.

The findings were published today in Clinical Gastroenterology and Hepatology.

Journal: Clinical Gastroenterology and Hepatology

7-Apr-2026

Study identifies PHIP as a novel dependency in cancers driven by SWI/SNF mutations

St. Jude Children's Research Hospital
Peer-Reviewed Publication

Discover research from St. Jude identifying PHIP as a novel dependency in cancers that have mutations in SWI/SNF

Journal: Nature Communications

7-Apr-2026

Adjuvant PD-1/PD-L1 inhibitors show efficacy but highlight safety considerations in solid cancers

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – April 7, 2026 – A new research paper was published in Volume 17 of Oncotarget on March 31, 2026, titled “Efficacy and safety of PD-1/ PD-L1 inhibitors as adjuvants in the treatment of patients with solid cancers: A systematic review and meta-analysis of randomized controlled trials.”

Journal: Oncotarget